Literatur
- 1
Pichichero M E, Green J L, Francis A B.
Recurrent group A streptococcal tonsillopharyngitis.
Pediatr Infect Dis J.
1998;
17
809-815
- 2
Beres S B, Sylva G L, Barbian K D.
Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins,
the high-virulence phenotype, and clone emergence.
Proc Natl Acad Sci USA.
2002;
99
10 078-10 083
- 3
Ferretti J J, McShan W M, Ajdic D.
Complete genome sequence of an M1 strain of Streptococcus pyogenes.
Proc Natl Acad Sci USA.
2001;
98
4658-4663
- 4
Smoot J C, Barbian K D, van Gompel J J.
Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus
strains associated with acute rheumatic fever outbreaks.
Proc Natl Acad Sci USA.
2002;
99
4668-4673
- 5
Banks D J, Beres S B, Musser J M.
The fundamental contribution of phages to GAS evolution, genome diversification and
strain emergence.
TRENDS Microbiol.
2002;
10
515-521
- 6
Robert Koch-Institut .
Ratgeber Infektionskrankheiten. 19. Folge: Scharlach und andere Infektionskrankheiten
durch Streptococcus pyogenes.
Epidemiol Bul.
2000;
43
343-345
- 7 Nationales Referenzzentrum für Streptokokken, Pauwelstr. 30, 52 057 Aachen, Tel.
0241 – 8 089 510.
- 8 Del Mar C B, Glasziou P P, Spinks A B. Antibiotics for sore throat. Cochrane Database
of Systematic Reviews 2006 Issue 4. Art. No.: CD000023. DOI: 10.1002/14 651 858.CD000023.pub.3
- 9
Robertson K A, Volmink J A, Mayosi B M.
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis.
BMC Cardiovascular disorders.
2005;
5-11
- 10 Deutsche Gesellschaft für pädiatrische Infektiologie (DGPI) .Handbuch. Infektionen
bei Kindern und Jugendlichen. 5. Aufl. Stuttgart; Thieme Verlag 2009
- 11
Casey J R, Pichichero M E.
Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal
tonsillopharyngitis in children.
Pediatrics.
2004;
113
866-882
- 12
Scholz H, Adam D.
Kurzzeittherapie der Streptokokken-Tonsillopharyngitis.
Dtsch Ärztebl.
2001;
98
399-1402
- 13
Adam D, Scholz H, Helmerking M.
Short-course antibiotic treatment of 4782 culture-proven cases of group A streptococcal
tonsillopharyngitis and incidence of poststreptococcal sequelae.
J Infect Dis.
2000;
182
509-516
- 14
Scholz H.
Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a
10-day course of penicillin V.
Chemother.
2004;
50
51-54
- 15
Cohen R.
Defining the optimum treatment regimen for Azithromycin in acute Tonsillopharyngitis.
Pediatr Infect Dis J.
2004;
23
129-134
- 16
Gerber M A, Randolph M F, Chanatry J, Wright L L, DeMeo K, Kaplan E L.
Five vs ten days of penicillin V therapy for streptococcal pharyngitis.
Am J Dis Child.
1987;
141
224-227
- 17
Tanz R R, Poncher J R, Corydon K E. et al .
Clindamycin treatment of chronic pharyngeal carriage of group A streptococci.
J Pediatr.
1991;
119
123-128
- 18
Cartwright K, Logan M, McNulty C. et al .
A cluster of cases of streptococcal necrotizing fasciitis in Gloucestershire.
Epidemiol Infect.
1995;
115
387-397
- 19
Aguero J, Ortega-Mendi M, Cano M E.
Outbreak of invasive group A streptococcal disease among children attending a day-care
center.
Pediatr Infect Dis J.
2008;
27
602-604
- 20
Kotb M, Norrby-Teglund A, McGeer A. et al .
An immunogenetic and molecular basis for differences in outcomes of invasive group
A streptococcal infections.
Nat Med.
2002;
8
1398-1404
- 21 Strep-EURO .http://www.strep-euro.lu.se
- 22
Lamagni T L, Darenberg J, Luca-Harari B. et al .
Epidemiology of severe Streptococcus pyogenes disease in Europe.
J Clin Microbiol.
2008;
46
2359-2367
- 23
Lamagni T L, Neal S, Keshishian C. et al .
Severe Streptococcus pyogenes infections, United Kingdom, 2003 – 2004.
Emerg Infect Dis.
2008;
14
202-209
- 24
Darenberg J, Ihendyane N, Sjölin J. et al, StreptIg Study Group .
Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European
randomized, double-blind, placebo-controlled trial.
Clin Infect Dis.
2003;
37
33-340
- 25
Kaul R, McGeer A, Norrby-Teglund A.
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome – a comparative
observational study. The Canadian Streptococcal Study Group.
Clin Infect Dis.
1999;
28
800-807
PD Dr. med. Horst Scholz
Straße 6, Nr. 23
13 125 Berlin
Telefon: 030/9415650
eMail: ho.scholz@t-online.de
